FR940318-0-00008 FR940318-0-00002 15. Section 145.53 is amended as follows: a. In paragraph (a), footnote 1 and its reference in the text are redesignated as footnote 7. b. The introductory text of paragraph (b)(3) is amended by removing the words ``, or a breeding flock composed of progeny of a primary breeding flock which is intended solely for the production of multiplier breeding flocks,''. c. Paragraph (b)(3)(v) is amended by removing the words ``S. pullorum or S. gallinarum isolations from poultry'' and adding the words ``any disease outbreak involving a disease covered under the Plan'' in their place, and by adding a proviso at the end of the paragraph to read as set forth below. §145.53 Terminology and classification: flocks and products. * * * * * (b)␣*␣*␣* (3)␣*␣*␣* (v)␣*␣*␣*␣Provided, That if the origin of the infection involves another State, or if there is exposure to poultry in another State from the infected flock, then the National Poultry Improvement Plan will conduct an investigation; * * * * * PART 147_AUXILIARY PROVISIONS ON NATIONAL POULTRY IMPROVEMENT PLAN 16. The authority citation for part 147 continues to read as follows: Authority: 7 U.S.C. 429; 7 CFR 2.17, 2.51, and 371.2(d). §§147.1, 147.2, and 147.3 [Amended] 17. In §§147.1, 147.2, and 147.3, at the end of the regulatory text of each section, the words ``(Approved by the Office of Management and Budget under control number 0579&hyph;0007)'' are added. §147.5 [Amended] 18. In §147.5, paragraph (b), footnote 1 and its reference in the text are redesignated as footnote 4, and the footnote is amended by removing the words ``Federal Building,'' and adding the words ``Presidential Building, 6525 Belcrest Road,'' in their place. 19. In §147.5, at the end of the regulatory text, the words ``(Approved by the Office of Management and Budget under control number 0579&hyph;0007)'' are added. §147.6 [Amended] 20. In §147.6, the introductory text of paragraph (b), the second sentence, the words ``or identified as infected by a polymerase chain reaction (PCR)-based procedure approved by the Department'' are added after the word ``bacteriologically''. 21. In §147.6, paragraph (b)(5), the second sentence, the words ``or a PCR-based procedure conducted on these specimens'' are added after the word ``individually''. 22. In §147.6, in paragraphs (b)(12) through (b)(15), the words ``, PCR-based procedures,'' are added after the words ``in vivo bio-assay'' each time they appear. 23. Section 147.7 is amended as follows: a. In the section heading, footnote 1 and its reference are redesignated as footnote 5. b. In the introductory text, the first sentence is amended by removing the words ``plate of the tube agglutination'' and adding the words ``plate agglutination test, the tube agglutination test, and the enzyme-linked immunosorbent assay (ELISA)'' in their place. c. In the introductory text, the beginning of the third sentence is amended by removing the word ``Both'' and adding the words ``These three'' in its place. d. In the introductory text, the seventh sentence is amended by removing the words ``the plate and/or'' and adding the words ``the ELISA, plate, and/or'' in their place. e. In paragraph (a), the paragraph heading and the first sentence of the introductory text of paragraph (a)(1) is amended by removing the words ``plate test'' and adding the words ``plate agglutination test'' in their place. f. Paragraph (e) is amended as follows: i. In the paragraph heading, the word ``test'' is removed and the word ``tests'' added in its place. ii. Paragraphs (e)(1) introductory text through (e)(3)(xi) are redesignated as follows: ␣ 1Old section 1New section 147.7(e)(1) introductory text 147.7(e)(1)(i) introductory text. 147.7(e)(1)(i) 147.7(e)(1)(i)(A). 147.7(e)(1)(ii) 147.7(e)(1)(i)(B). 147.7(e)(1)(iii) 147.7(e)(1)(i)(C). 147.7(e)(1)(iv) 147.7(e)(1)(i)(D). 147.7(e)(2) introductory text 147.7(e)(1)(ii) introductory text. 147.7(e)(2)(i) 147.7(e)(1)(ii)(A). 147.7(e)(2)(ii) 147.7(e)(1)(ii)(B). 147.7(e)(2)(iii) 147.7(e)(1)(ii)(C). 147.7(e)(2)(iv) 147.7(e)(1)(ii)(D). 147.7(e)(2)(v) 147.7(e)(1)(ii)(E). 147.7(e)(2)(vi) 147.7(e)(1)(ii)(F). 147.7(e)(2)(vii) 147.7(e)(1)(ii)(G). 147.7(e)(2)(viii) 147.7(e)(1)(ii)(H). 147.7(e)(3) introductory text 147.7(e)(1)(iii) introductory text. 147.7(e)(3)(i) 147.7(e)(1)(iii)(A). 147.7(e)(3)(ii) 147.7(e)(1)(iii)(B). 147.7(e)(3)(iii) 147.7(e)(1)(iii)(C). 147.7(e)(3)(iv) 147.7(e)(1)(iii)(D). 147.7(e)(3)(v) 147.7(e)(1)(iii)(E). 147.7(e)(3)(vi) 147.7(e)(1)(iii)(F). 147.7(e)(3)(vii) 147.7(e)(1)(iii)(G). 147.7(e)(3)(viii) 147.7(e)(1)(iii)(H). 147.7(e)(3)(ix) 147.7(e)(1)(iii)(I). 147.7(e)(3)(x) introductory text 147.7(e)(1)(iii)(J) introductory text. 147.7(e)(3)(x)(A) 147.7(e)(1)(iii)(J)( 1 ). 147.7(e)(3)(x)(B) 147.7(e)(1)(iii)(J)( 2 ). 147.7(e)(3)(x)(C) 147.7(e)(1)(iii)(J)( 3 ). 147.7(e)(3)(x)(D) 147.7(e)(1)(iii)(J)( 4 ). 147.7(e)(3)(x)(E) 147.7(e)(1)(iii)(J)( 5 ). 147.7(e)(3)(x)(F) 147.7(e)(1)(iii)(J)( 6 ). 147.7(e)(3)(x)(G) 147.7(e)(1)(iii)(J)( 7 ). 147.7(e)(3)(x)(H) 147.7(e)(1)(iii)(J)( 8 ). 147.7(e)(3)(x)(I) 147.7(e)(1)(iii)(J)( 9 ). 147.7(e)(3)(xi) 147.7(e)(1)(iii)(K). iii. The introductory text of paragraph (e) is redesignated as paragraph (e)(1) and a new paragraph heading for paragraph (e)(1) is added to read as set forth below. iv. A new paragraph (e)(2) is added to read as set forth below. §147.7 Standard test procedures for mycoplasma. 5 5 For additional information on mycoplasma test procedures, refer to the following references: Proc. 77th Annual Meeting, U.S. Animal Health Association, 1973; Isolation and Identification of Avian Pathogens, 2nd Edition; Methods for Examining Poultry Biologics and for Identifying and Quantifying Avian Pathogens, 1971. * * * * * (e)␣*␣*␣* (1) Procedure No. 1.␣*␣*␣* * * * * * (2) Procedure No. 2. Purpose: To test for antibodies to avian mycoplasma by hemagglutination inhibition (HI). The test uses the constant antigen, titered-sera method for measuring antibodies to M. gallisepticum, M. synoviae, or M. meleagridis. (i) Materials needed. (A) M. gallisepticum, M. synoviae , and/or M. meleagridis HI antigens. (B) Positive and negative control sera. (C) Phosphate buffered saline (PBS). (D) Microtiter plates, 96-well, U-bottom.
